Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Gastroenterology
Published in: BMC Gastroenterology 1/2024

Open Access 01-12-2024 | Irritable Bowel Syndrome | Research

Comparing the effectiveness of transdiagnostic treatment with acceptance and commitment therapy on emotional disorders, rumination, and life satisfaction in patients with irritable bowel syndrome: a randomized clinical trial

Authors: Homa Shahkaram, Jafar Sarani Yaztappeh, Amir Sadeghi, Amir Sam Kianimoghadam, Samaneh Soltanabadi, Maryam Bakhtiari, Abbas Masjedi Arani

Published in: BMC Gastroenterology | Issue 1/2024

Login to get access

Abstract

Objective

The present study was conducted to compare the effectiveness of transdiagnostic treatment (UP) with the acceptance and commitment therapy (ACT) on the emotional disorders, rumination, and life satisfaction in the patients with irritable bowel syndrome (IBS).

Method

The present study was a randomized clinical trial with a pre-test and post-test design. Between the winter of 2021 and the end of spring 2022, Taleghani Hospital in Tehran received referrals from the statistical population of IBS patients. Of them, 30 individuals (15 in each group) were chosen by convenience sampling and then randomly allocated to groups. UP (It is emotion-based and intervenes in comorbid symptoms), and ACT treatments were provided to the participants online. The participants in the UP and ACT groups received the desired treatments in eight weekly sessions of 45–60 min.

Results

There was no significant difference between UP pre-test and ACT regarding depression, anxiety, rumination, and life satisfaction (P > 0.05). There was no significant difference between UP and ACT post-test in terms of depression, rumination, and life satisfaction (P > 0.05), but due to anxiety, their difference was significant (P < 0.05). Besides, there was a significant difference between pre-test and post-test phases of UP and ACT regarding depression, anxiety, and rumination (P < 0.05). Still, they had no significant difference regarding life satisfaction (P > 0.05).

Conclusion

Therefore, it is suggested that specialists use UP and ACT as effective psychological treatments for the emotional symptoms of IBS patients to improve psychological symptoms.
Literature
1.
Ford AC, Sperber AD, Corsetti M, Camilleri M. Irritable bowel syndrome. Lancet. 2020;396(10263):1675–88.PubMedCrossRef
2.
Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313(9):949–58.PubMedCrossRef
3.
Jahangiri P, Jazi MSH, Keshteli AH, Sadeghpour S, Amini E, Amini E, Adibi P. Irritable bowel syndrome in Iran: SEPAHAN systematic review No. 1. International journal of preventive medicine. 2012;3(Suppl1):1–9.
4.
Akhondi N, Memarmontazareyn S, Saneei P, Hassanzadeh-Keshteli A, Esmaillzadeh A, Adibi P. The association of irritable bowel syndrome and obesity in iranian adults. J Isfahan Med Sch. 2016;34(396):1007–12 Persian.
5.
6.
Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology. 2002;123(6):2108–31.PubMedCrossRef
7.
Szigethy E, Murphy SM, Ehrlich OG, Engel-Nitz NM, Heller CA, Henrichsen K, et al. Mental health costs of inflammatory bowel diseases. Inflamm Bowel Dis. 2021;27(1):40–8.PubMedCrossRef
8.
9.
Gholamrezaei A, Minakari M, Nemati K, Daghaghzadeh H, Tavakkoli H, Dehcord MHAN. Extra-intestinal Symptoms and their Relationship to Psychological Symptoms in Patients withIrritable Bowel Syndrome. Govaresh. 2011;15(2):88–94 Persian.
10.
Choung RS, Locke GR 3rd, Zinsmeister AR, Schleck CD, Talley NJ. Psychosocial distress and somatic symptoms in community subjects with irritable bowel syndrome: a psychological component is the rule. Am J Gastroenterol. 2009;104(7):1772–9.PubMedPubMedCentralCrossRef
11.
Zamani M, Alizadeh-Tabari S, Zamani V. Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2019;50(2):132–43.PubMedCrossRef
12.
Levy R, Olden K, Naliboff B, Bradley L, Francisconi C, Drossman D, et al. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology. 2006;130(5):1447–58.PubMedCrossRef
13.
Folks D. The interface of psychiatry and irritable bowel syndrome. Curr Psychiatry Rep. 2004;6(3):201–15.CrossRef
14.
Mohammadkhani S, Shahidi E, Daryani NE. Efficacy of Hypnotherapy on Symptoms Severity and Rumination of Patients with Irritable Bowel Syndrome. Govaresh. 2019;24(3):163–9 Persian.
15.
Dargahiyan R, Mohammad Khani S, Hassani J, Shams J. The Effectiveness of Metacognitive Therapy on Improvement of Metacognitive Beliefs, Rumination and Depressive Symptoms: A Single Subject Study. Clin Psychol Stud. 2011;1(3):81–104 Persian.
16.
Fond G, Loundou A, Hamdani N, Boukouaci W, Dargel A, Oliveira J, et al. Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis. European Archives of Psychiatry and Clinical Neuroscience. 2014;264:651–60.PubMedCrossRef
17.
Farahmand Dehghanpoor Varnamkhasti F, Yousefi Z. Multiple relationships between rumination and mood with frightening dreams. Iranian journal of psychiatry and clinical psychology. 2016;22(2):85–92 Persian.
18.
Gebhardt W, Van Der Doef M, Massey E, Verhoeven C, Verkuil B. Goal commitment to finding a partner and satisfaction with life among female singles: The mediating role of rumination. Journal of health psychology. 2010;15(1):122–30.PubMedCrossRef
19.
Jain S, Shapiro SL, Swanick S, Roesch SC, Mills PJ, Bell I, et al. A randomized controlled trial of mindfulness meditation versus relaxation training: Effects on distress, positive states of mind, rumination, and distraction. Annals of behavioral medicine. 2007;33:11–21.PubMedCrossRef
20.
Takagishi Y, Sakata M, Kitamura T. I nfluence of rumination and self-efficacy on depression in J apanese undergraduate nursing students. Asian Journal of Social Psychology. 2013;16(3):163–8.CrossRef
21.
Zawadzki MJ, Graham JE, Gerin W. Rumination and anxiety mediate the effect of loneliness on depressed mood and sleep quality in college students. Health Psychology. 2013;32(2):212–22.PubMedCrossRef
22.
Tunheim K, Dammen T, Baardstu S, Moum T, Munkhaugen J, Papageorgiou C. Relationships between depression, anxiety, type D personality, and worry and rumination in patients with coronary heart disease. Front Psychol. 2022;13: 929410.PubMedPubMedCentralCrossRef
23.
Meyer C, Rumpf H-J, Hapke U, John U. Impact of psychiatric disorders in the general population: satisfaction with life and the influence of comorbidity and disorder duration. Social psychiatry and psychiatric epidemiology. 2004;39:435–41.PubMedCrossRef
24.
Almquist E, Törnblom H, Simren M. Practical management of irritable bowel syndrome: a clinical review. Minerva Gastroenterol Dietol. 2015;62(1):30–48.PubMed
25.
Bazaliński D, Sałacińska I, Więch P, Kózka M. Life satisfaction and self-efficacy in patients with stoma. Progress in Health Sciences. 2014;4(2):22–30.
26.
27.
Drossman DA. 2012 David Sun lecture: helping your patient by helping yourself–how to improve the patient-physician relationship by optimizing communication skills. Am J Gastroenterol. 2013;108(4):521–8.PubMedCrossRef
28.
Abasi I, Fata L, Sadeghi M, Banihashemi S, Mohammadee A. A comparison of transdiagnostic components in generalized anxiety disorder, unipolar mood disorder and nonclinical population. Int J Psychol Behav Sci. 2013;7(12):803–11 Persian.
29.
Barlow DH, Harris BA, Eustis EH, Farchione TJ. The unified protocol for transdiagnostic treatment of emotional disorders. World Psychiatry. 2020;19(2):245–6.PubMedPubMedCentralCrossRef
30.
Farchione TJ, Fairholme CP, Ellard KK, Boisseau CL, Thompson-Hollands J, Carl JR, et al. Unified protocol for transdiagnostic treatment of emotional disorders: a randomized controlled trial. Behavior therapy. 2012;43(3):666–78.PubMedPubMedCentralCrossRef
31.
Bravo Ferreira N, Eugenicos M, Graham Morris P, Gillanders D. Using acceptance and commitment therapy in irritable bowel syndrome. Gastrointestinal Nursing. 2011;9(9):28–35.CrossRef
32.
Ferreira NB, Gillanders D, Morris PG, Eugenicos M. Pilot study of acceptance and commitment therapy for irritable bowel syndrome: A preliminary analysis of treatment outcomes and processes of change. Clinical Psychologist. 2018;22(2):241–50.CrossRef
33.
Hayes SC, Pistorello J, Levin ME. Acceptance and commitment therapy as a unified model of behavior change. The Counseling Psychologist. 2012;40(7):976–1002.CrossRef
34.
Hayes SC, Strosahl KD, Wilson KG. Acceptance and commitment therapy. New York: Guilford press; 1999.
35.
Dindo L, Van Liew JR, Arch JJ. Acceptance and Commitment Therapy: A Transdiagnostic Behavioral Intervention for Mental Health and Medical Conditions. Neurotherapeutics. 2017;14(3):546–53.PubMedPubMedCentralCrossRef
36.
Black CJ, Thakur ER, Houghton LA, Quigley EMM, Moayyedi P, Ford AC. Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis. Gut. 2020;69(8):1441–51.PubMedCrossRef
37.
Ito M, Muto T. Effectiveness of acceptance and commitment therapy for irritable bowel syndrome non-patients: A pilot randomized waiting list controlled trial. Journal of Contextual Behavioral Science. 2020;15:85–91.CrossRef
38.
Mohsenabadi H, Zanjani Z, Shabani MJ, Arj A. A randomized clinical trial of the Unified Protocol for Transdiagnostic treatment of emotional and gastrointestinal symptoms in patients with irritable bowel syndrome: evaluating efficacy and mechanism of change. Journal of psychosomatic research. 2018;113:8–15.PubMedCrossRef
39.
Pashang S, khosh Lahjeh Sedgh A. Acceptance and Commitment Therapy Compared with Metacognition Therapy in Reducing Symptoms and Increasing Life Satisfaction in Patients with Irritable Bowel Syndrome. Govaresh. 2019;24(1):22–9 Persian.
40.
Schulz KF, Grimes DA. Generation of allocation sequences in randomised trials: chance, not choice. The Lancet. 2002;359(9305):515–9.CrossRef
41.
Barlow DH, Farchione TJ, Fairholme CP, al e. Unified protocol for transdiagnostic treatment of emotional disorders: Therapist guide. Oxford: Oxford University Press; 2011.
42.
Barlow D, Ellard K, Fairholme C, al e. The unified protocol for transdiagnostic treatment of emotional disorders: Client workbook. New York: Oxford University Press; 2011.
43.
Danesh-Mirkohan RA, Taklavi S, Kazemi R. Comparing the Effectiveness of Acceptance and Commitment Therapy with Mindfulness Based Cognitive Therapy, On Self-Control and Emotional Flexibility in Women with Compulsive Buying. Rooyesh-e-Ravanshenasi Journal (RRJ). 2021;10(5):13–24 Persian.
44.
Lovibond PF, Lovibond SH. The structure of negative emotional states: Comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behaviour research and therapy. 1995;33(3):335–43.PubMedCrossRef
45.
Thiyagarajan A, James TG, Marzo RR. Psychometric properties of the 21-item Depression, Anxiety, and Stress Scale (DASS-21) among Malaysians during COVID-19: a methodological study. Humanities and Social Sciences Communications. 2022;9(1):1–8.CrossRef
46.
Kakemam E, Navvabi E, Albelbeisi AH, Saeedikia F, Rouhi A, Majidi S. Psychometric properties of the Persian version of Depression Anxiety Stress Scale-21 Items (DASS-21) in a sample of health professionals: a cross-sectional study. BMC Health Services Research. 2022;22(1):1–9.CrossRef
47.
Nolen-Hoeksema S, Morrow J. A prospective study of depression and posttraumatic stress symptoms after a natural disaster: the 1989 Loma Prieta Earthquake. Journal of personality and social psychology. 1991;61(1):115–21.PubMedCrossRef
48.
Treynor W, Gonzalez R, Nolen-Hoeksema S. Rumination reconsidered: A psychometric analysis. Cognitive therapy and research. 2003;27:247–59.CrossRef
49.
Mardani‌ M, Hamid N. Investigating the mediating role of rumination in the relationship between insecure attachment styles and depression in outpatient psychiatric disorders. Rooyesh-e-Ravanshenasi journal (RRJ). 2021;10(3):111–20 Persian.
50.
Diener ED, Emmons RA, Larsen RJ, Griffin S. The satisfaction with life scale. J Pers Assess. 1985;49(1):71–5.PubMedCrossRef
51.
Bayani AA, Koocheky AM, Goodarzi H. The reliability and validity of the satisfaction with life scale. J Dev Psychol. 2007;3(11):259–65 Persian.
52.
Azizi A, Mohamadi J. Effectiveness of dialectical group behavior therapy on perceived stress and depression in patients with irritable bowel syndrome. J Ardabil Univ Med Sci. 2016;16(1):95–104 Persian.
53.
Zemestani M, Imani M. Effectiveness of transdiagnostic treatment on depression/anxiety symptoms and emotion regulation. Contemp Psychol. 2016;11(1):21–32 Persian.
54.
Karimian Z, Haghayegh SA, Emami-Najafi-Dehkordi SM, Raisi M. The Comparison of the Effectiveness of Trans-diagnostic Treatment and the Acceptance and Commitment Therapy (ACT) on Emotion Regulation and Illness Perception in Patients with Irritable Bowel Syndrome (IBS). J Res Behav Sci. 2021;19(3):477–88 Persian.CrossRef
55.
Sharif Ara B, Khosropour F, Molayi ZH. Effectiveness of Acceptance and Commitment Therapy (ACT) on Emotional Processing, Irrational Beliefs and Rumination in Patients with Generalized Anxiety Disorder. Journal of Fundamentals of Mental Health. 2023;4(4):34–44.
56.
Shirazipour MM. The effectiveness of treatment based on acceptance and commitment to reduce rumination and worry about body image of the elderly with depression. J Fundamentals Ment Health. 2022.
57.
Nasri M, Ahadi H, Dortaj F. Effectiveness of Transdiagnostic Treatment on Rumination and Cognitive Avoidance in Patients with Type 2 Diabetes. J Psychol Stud. 2018;14(2):41–56 Persian.
58.
Feldman G, Dunn E, Stemke C, Bell K, Greeson J. Mindfulness and rumination as predictors of persistence with a distress tolerance task.Personality and individual differences. 2014;56:154–8.CrossRef
59.
KoohneshinTaromi F, Afsharinia K, Kakabraee K. Comparison of the Effectiveness of Acceptance and Commitment-Based Therapy (ACT) and Meta-Diagnostic Therapy in Reducing Emotional Problems and Increasing Life Satisfaction in Nurses. Psychol Methods Models. 2021;12(43):55–69 Persian.
60.
Nosrati R, Momeni KH, Mazdeh M, Karami J. The relationship between psychological capital and acceptance of the disease with life satisfaction in patients with multiple sclerosis. J Health Care. 2018;20(2):114–22 Persian.CrossRef
Metadata
Title
Comparing the effectiveness of transdiagnostic treatment with acceptance and commitment therapy on emotional disorders, rumination, and life satisfaction in patients with irritable bowel syndrome: a randomized clinical trial
Authors
Homa Shahkaram
Jafar Sarani Yaztappeh
Amir Sadeghi
Amir Sam Kianimoghadam
Samaneh Soltanabadi
Maryam Bakhtiari
Abbas Masjedi Arani
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2024
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-024-03142-w

Other articles of this Issue 1/2024

BMC Gastroenterology 1/2024 Go to the issue

Research

Preventive and therapeutic effects of rifaximin on hepatic encephalopathy with differential application dosages and strategies: a network meta-analysis

Research

Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study

Research

Endoscopic diagnosis of gastric and oesophageal cancer in Lusaka, Zambia: a retrospective analysis

Research

The association between hemoglobin level and sarcopenia in Chinese patients with Crohn’s disease

Research

Impact of severe postoperative complications on the prognosis of older patients with colorectal cancer: a two-center retrospective study

Research

Clinical study on the necessity and feasibility of routine MRCP in patients with cholecystolithiasis before LC
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits